Key Mechanisms of Action: Stimulates Lipolysis (Fat Breakdown) AOD-9604 activates beta-3 adrenergic receptors in adipose (fat) tissue, triggering the release of stored fatty acids for energy use
This is the most conservative protocol and serves as the starting point for patients who are new to peptide therapy or who have multiple mild concerns rather than one acute target
The results of the secondary analysis of this study published in 2021 proposed a new idea that multiple, but not single, exposures might cause adverse effects on specific neuropsychological domains, such as processing speed, fine motor abilities, motor skills, and visual-motor integration (Warner et al., 2018, 2021)
Retatrutide (LY3437943) represents a paradigm shift from dual GLP-1/GIP agonists to a triple-receptor agonist , uniquely targeting GIP, GLP-1, and glucagon receptors